A broad spectrum of neutrophils, macrophages and myeloid-derived suppressor cells (MDSCs) characterized by positivity for CD11b and GR1 (Ly6G/C) have been found to be associated with refractoriness to anti-VEGF therapy in multiple murine tumor models (35). The gene discussed is VEGFA; the disease is neoplasm.